Koopman Wj

450 total citations
13 papers, 345 citations indexed

About

Koopman Wj is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Koopman Wj has authored 13 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Koopman Wj's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and HER2/EGFR in Cancer Research (2 papers). Koopman Wj is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and HER2/EGFR in Cancer Research (2 papers). Koopman Wj collaborates with scholars based in United States. Koopman Wj's co-authors include Roberta Hanna, Larry W. Moreland, Alarcón Gs, Akihiko Tanaka, Acton Rt, D Kaplan, Brandt Kd, Greenwald Ra, Altman Rd and Hochberg Mc and has published in prestigious journals such as PubMed.

In The Last Decade

Koopman Wj

12 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koopman Wj United States 7 228 103 80 68 36 13 345
N. Amos United Kingdom 11 214 0.9× 184 1.8× 54 0.7× 146 2.1× 46 1.3× 15 403
H Schotte Germany 11 184 0.8× 140 1.4× 27 0.3× 41 0.6× 43 1.2× 19 349
N Thumb Austria 10 163 0.7× 79 0.8× 26 0.3× 89 1.3× 19 0.5× 49 357
Concepción Moll Spain 7 195 0.9× 105 1.0× 41 0.5× 54 0.8× 53 1.5× 12 342
G. Tokgöz Türkiye 10 179 0.8× 51 0.5× 50 0.6× 33 0.5× 15 0.4× 24 345
Janice L. Lookabaugh United States 4 127 0.6× 64 0.6× 53 0.7× 35 0.5× 37 1.0× 8 348
K.J.M. Assmann Netherlands 10 195 0.9× 194 1.9× 40 0.5× 94 1.4× 11 0.3× 12 448
M Viana Queiróz Portugal 11 198 0.9× 89 0.9× 42 0.5× 65 1.0× 35 1.0× 23 348
J Edelman Australia 10 250 1.1× 50 0.5× 107 1.3× 15 0.2× 25 0.7× 18 400
James Ja United States 10 226 1.0× 149 1.4× 22 0.3× 82 1.2× 19 0.5× 16 337

Countries citing papers authored by Koopman Wj

Since Specialization
Citations

This map shows the geographic impact of Koopman Wj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koopman Wj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koopman Wj more than expected).

Fields of papers citing papers by Koopman Wj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koopman Wj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koopman Wj. The network helps show where Koopman Wj may publish in the future.

Co-authorship network of co-authors of Koopman Wj

This figure shows the co-authorship network connecting the top 25 collaborators of Koopman Wj. A scholar is included among the top collaborators of Koopman Wj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koopman Wj. Koopman Wj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Moreland, Larry W., et al.. (1996). Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.. PubMed. 23(11). 1849–55. 152 indexed citations
2.
Wj, Koopman, et al.. (1996). Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis.. PubMed. 23(11). 1845–8. 5 indexed citations
3.
Wj, Koopman, et al.. (1994). Survival impact of autoantibodies in systemic lupus erythematosus.. PubMed. 21(2). 224–8. 23 indexed citations
4.
Wj, Koopman. (1992). Expressing our inner thoughts: how to organize and write a clinical research project grant application.. PubMed. 33. 16–9.
5.
Moreland, Larry W., et al.. (1992). Digital subtraction radiography for the assessment of bone changes in rheumatoid arthritis.. PubMed. 19(11). 1697–703. 4 indexed citations
6.
Tanaka, Akihiko, et al.. (1988). Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice: II. Ultrastructural basis of joint destruction.. PubMed. 15(1). 10–6. 42 indexed citations
7.
Wj, Koopman, et al.. (1987). Differential expression of IgA- and IgM-rheumatoid factors in human disease: evidence for independent regulation of rheumatoid factor isotype production.. PubMed. 216B. 1627–39. 6 indexed citations
8.
Rd, Altman, Brandt Kd, Greenwald Ra, et al.. (1987). Development of clinical criteria for osteoarthritis.. PubMed. 14 Spec No. 3–6. 60 indexed citations
9.
Wyatt, Robert, et al.. (1987). Immunological studies of IgA nephropathy: familial and racial aspects.. PubMed. 216B. 1489–98. 6 indexed citations
10.
Gs, Alarcón & Koopman Wj. (1985). The carpometarcarpal ratio: a useful method for assessing disease progression in rheumatoid arthritis.. PubMed. 12(5). 846–8. 6 indexed citations
11.
Gs, Alarcón, et al.. (1983). DR antigen distribution in Blacks with rheumatoid arthritis.. PubMed. 10(4). 579–83. 25 indexed citations
12.
Wj, Koopman, et al.. (1983). Local synthesis of IgM and IgM rheumatoid factor in rheumatoid pleuritis.. PubMed. 10(2). 204–9. 15 indexed citations
13.
Wj, Koopman, Orange Rp, & Austen Kf. (1970). Inhibition by antihistamines of the immunologic release of slow reacting substance of anaphylaxis (SRS-A) in the rat.. PubMed. 83. 225–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026